SpyGlass Pharma Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About SpyGlass Pharma Inc.
SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. The company is developing two programs: the BIM-IOL System, which is intended for use during cataract surgery to deliver glaucoma treatment, and the BIM-DRS, which is designed for glaucoma patients who are not undergoing cataract surgery.
/ 
Others were interested in
Frequently asked questions
To buy SpyGlass Pharma Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for SpyGlass Pharma Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for SpyGlass Pharma Inc. is SGP:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
SpyGlass Pharma Inc. has its primary listing on NASDAQ. You can trade SpyGlass Pharma Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, SpyGlass Pharma Inc. is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include SpyGlass Pharma Inc. as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like SpyGlass Pharma Inc. or others.